Danielle Wang
Internal Medicine • Orange, CA
101 The City Dr S, Suite 400
Orange, CA 928683201
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 26, 2016; this date does not establish years in practice.
-
Published CMS data list 55,385 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J3262 — Injection, tocilizumab, 1 mg: 15,742 service units.
- J1439 — Injection, ferric carboxymaltose, 1 mg: 13,500 service units.
- J3111 — Injection, romosozumab-aqqg, 1 mg: 11,340 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 63 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 457 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisone — 60 prescription fills, including refills.
- Gabapentin — 50 prescription fills, including refills.
- Methotrexate (Methotrexate Sodium) — 47 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 17 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Orange, CA (2024, 91 clinicians with data). Median for this group: 653. Middle half: 275 to 1,144.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in California (2024, 8,014 clinicians with data). Median for this group: 546. Middle half: 197 to 1,236.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,426 in 2021 to 55,385 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2021–2024.
Practice Location & Contact Primary Location
101 The City Dr S
Suite 400
Orange, CA 928683201
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Center For Rheumatology Medical Corporation. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
University Of California, Irvine, California College Of Medicine
2016
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
338 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $535,255 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $427,828 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
596 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$81,440 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $496.45 across 22 records.
By nature of payment
- Food and Beverage: $496.45 across 22 records.
Reporting-company totals
- ABBVIE INC.: $471.04 across 21 records.
- Amgen Inc.: $25.41 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
10 years (graduated 2016)
CMS Doctors and Clinicians data list 2016 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Danielle Wang has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Danielle Wang as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Orange and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Orange, CA (2024, 91 clinicians with data). Median for this group: 653. Middle half: 275 to 1,144.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in California (2024, 8,014 clinicians with data). Median for this group: 546. Middle half: 197 to 1,236.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Orange, CA (2024, 91 clinicians with data). Median for this group: $64,689. Middle half: $30,651 to $94,868.
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in California (2024, 8,014 clinicians with data). Median for this group: $57,258. Middle half: $20,378 to $125,504.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Orange, CA (2024, 91 clinicians with data). Median for this group: $47,202. Middle half: $23,241 to $74,439.
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in California (2024, 8,014 clinicians with data). Median for this group: $43,360. Middle half: $14,871 to $95,733.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Internal Medicine in Orange, CA (2024, 109 clinicians with data). Median for this group: 546. Middle half: 101 to 2,251.
Fewer Part D prescriptions than 60% of clinicians listed under Internal Medicine in California (2024, 10,856 clinicians with data). Median for this group: 1,234. Middle half: 145 to 4,216.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under Internal Medicine in Orange, CA (2024, 109 clinicians with data). Median for this group: $50,471. Middle half: $2,520 to $217,115.
Close to the middle for clinicians listed under Internal Medicine in California (2024, 10,856 clinicians with data). Median for this group: $86,595. Middle half: $7,293 to $305,458.
189 active clinicians are listed under Internal Medicine with a practice address in Orange, CA (17,897 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Orange
23.3% of these 189 clinicians have the CMS telehealth indicator.
67.7% of these 189 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 3784% from 1,426 in 2021 to 55,385 in 2024.
- 2021: 1,426
- 2022: 5,616
- 2023: 34,976
- 2024: 55,385
-
Medicare-allowed amount
Medicare-allowed amount increased 1164% from $42,350 in 2021 to $535,255 in 2024.
- 2021: $42,350
- 2022: $155,769
- 2023: $337,573
- 2024: $535,255
-
Paid by Medicare
Paid by Medicare increased 1096% from $35,774 in 2021 to $427,828 in 2024.
- 2021: $35,774
- 2022: $128,874
- 2023: $272,658
- 2024: $427,828
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 702% from 57 in 2020 to 457 in 2024.
- 2020: 57
- 2021: 76
- 2022: 205
- 2023: 361
- 2024: 457
-
30-day fills
30-day fills increased 672% from 77 in 2020 to 596 in 2024.
- 2020: 77
- 2021: 118
- 2022: 259
- 2023: 437
- 2024: 596
-
Part D drug cost
Part D drug cost increased 49% from $54,759 in 2020 to $81,440 in 2024.
- 2020: $54,759
- 2021: $61,609
- 2022: $5,750
- 2023: $8,710
- 2024: $81,440
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $269.54 in 2021 to $496.45 in 2025.
- 2021: $269.54
- 2022: $888.03
- 2023: $265.22
- 2024: $283.44
- 2025: $496.45
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 22 records totaling $496.45.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $124.99 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
KRYSTEXXA | General | $25.41 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $19.38 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $19.06 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $19.01 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $18.90 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $18.82 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $18.81 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $18.78 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $18.09 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $18.06 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.71 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.70 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.53 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.44 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.18 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.18 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.13 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $17.07 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $16.84 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $14.44 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $6.92 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2020–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2021–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J3262
Injection, tocilizumab, 1 mg
|
15,742 | 11 | $9.00 | $5.44 |
|
J1439
Injection, ferric carboxymaltose, 1 mg
|
13,500 | 13 | $4.67 | $1.11 |
|
J3111
Injection, romosozumab-aqqg, 1 mg
|
11,340 | 14 | $24.00 | $10.79 |
|
J0717
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
|
6,000 | 12 | $12.00 | $4.45 |
|
J0897
Injection, denosumab, 1 mg
|
2,760 | 34 | $55.00 | $25.78 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
965 | 117 | $10.00 | $0.98 |
|
36415
Insertion of needle into vein for collection of blood sample
|
394 | 200 | $15.00 | $8.56 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
334 | 166 | $45.00 | $7.56 |
|
80053
Blood test, comprehensive group of blood chemicals
|
317 | 166 | $105.00 | $10.28 |
|
85651
Red blood cell sedimentation rate, to detect inflammation, non-automated
|
314 | 158 | $19.98 | $4.15 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
312 | 171 | $150.32 | $99.45 |
|
86140
Measurement c-reactive protein for detection of infection or inflammation
|
311 | 156 | $42.00 | $5.04 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
294 | 179 | $375.00 | $139.95 |
|
82784
Gammaglobulin (immune system protein) measurement
|
246 | 64 | $35.00 | $9.09 |
|
86235
Measurement of antibody for assessment of autoimmune disorder, any method
|
245 | 32 | $75.00 | $17.44 |
|
96401
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
|
232 | 70 | $185.00 | $83.60 |
|
J7050
Infusion, normal saline solution, 250 cc
|
184 | 60 | $45.00 | $0.64 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
137 | 47 | $525.00 | $149.61 |
|
96372
Injection of drug or substance under skin or into muscle
|
119 | 79 | $60.00 | $16.01 |
|
20610
Aspiration and/or injection of fluid from large joint
|
93 | 56 | $175.00 | $66.13 |
|
86160
Measurement of complement (immune system proteins), antigen,
|
83 | 67 | $51.00 | $11.73 |
|
86161
Measurement of complement function (immune system proteins)
|
82 | 66 | $42.00 | $11.73 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
80 | 35 | $126.88 | $61.05 |
|
83520
Measurement of substance using immunoassay technique
|
76 | 32 | $52.00 | $16.85 |
|
82306
Vitamin d-3 level
|
68 | 59 | $99.00 | $29.01 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisone | Prednisone | 60 | 1,328 | $380.03 | 15 |
| Gabapentin | Gabapentin | 50 | 2,060 | $381.30 | 24 |
| Methotrexate | Methotrexate Sodium | 47 | 2,351 | $653.43 | 12 |
| Leflunomide | Leflunomide | 46 | 2,158 | $2,185.29 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 41 | 1,530 | $813.60 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 35 | 1,177 | $298.60 | 23 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 35 | 1,174 | $601.42 | — |
| Tramadol Hcl | Tramadol Hcl | 22 | 478 | $99.86 | 14 |
| Colchicine | Colchicine | 18 | 1,060 | $694.58 | — |
| Pregabalin | Pregabalin | 17 | 570 | $140.12 | — |
| Allopurinol | Allopurinol | 16 | 720 | $68.76 | — |
| Celecoxib | Celecoxib | 13 | 375 | $122.88 | — |
| Probenecid | Probenecid | 12 | 360 | $504.60 | — |
| Morphine Sulfate Er | Morphine Sulfate | 12 | 340 | $120.31 | — |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 11 | 257 | $395.81 | — |
| Forteo | Teriparatide | 11 | 308 | $45,422.52 | — |
| Tymlos | Abaloparatide | 11 | 330 | $28,556.86 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-08-10NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - RHEUMATOLOGY
I20210816003694
CA
0345503322
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Center For Rheumatology Medical Corporation
8640 W 3rd St, Los Angeles, CA 900483386
Phone: 3106597878
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant - Medical
Physician Assistant (Certified)
Student in an Organized Health Care Education/Training Program
Doctor of Medicine (M.D.)
Anesthesiology
Doctor of Medicine (M.D.)
Surgery - Trauma Surgery
Doctor of Medicine (M.D.)
Hospitalist
Doctor of Medicine (M.D.)
Anesthesiology
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 8640 W 3RD ST, STE 300, LOS ANGELES, CA 900483386 (Tel: 3106597878)
Internal Medicine (license number reported to NPPES: CA A153619)
NPI status registered as active in NPPES database
Registered at 101 THE CITY DR S, SUITE 400, ORANGE, CA 928683201 (Tel: 7144567890)
Registered at 333 CITY BLVD W, SUITE 400, ORANGE, CA 928682903 (Tel: 7144565691)
Recorded as DANIELLE WANG
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Orange
- Dr. Alexander Watson, MD
- Dr. Mohamad Albouidani, MD
- Haleh Safavi
- Dr. Alex Zand, MD
- Dr. Kevin Mcbride, MD
- Dr. Rosine Bekarian, DO
Mailing Address
8640 W 3rd St, Ste 300
Los Angeles, CA 900483386
Phone: 3106597878